{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-067483","form_type":"8-K","ticker":null,"cik":"0001832415","company_name":"Better Therapeutics, Inc.","filed_at":"2024-03-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.833227+00:00","generated_at":"2026-06-04T21:36:21.580377+00:00","sec_items":["3.01","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"Better Therapeutics to terminate employees, seek wind-down or sale after Nasdaq delisting","bullets":["Board decided March 13, 2024 to terminate all employees and explore strategic alternatives including assignment for creditors or wind-down.","Company voluntarily requested delisting from Nasdaq; expects near-term delisting and intends to file Form 15 to suspend SEC reporting.","No financial terms disclosed; company had been non-compliant with Nasdaq min bid price and market value since Dec 2023.","Stock symbol BTTX on Nasdaq Capital Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-067483","json":"https://secwatch.observer/filing/0001193125-24-067483.json","markdown":"https://secwatch.observer/filing/0001193125-24-067483.md","text":"https://secwatch.observer/filing/0001193125-24-067483.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1832415/000119312524067483/0001193125-24-067483-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1832415/000119312524067483/d792547d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T21:36:21.580377+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2daa1ec48d0f5f17d970251422648d819acc045f","claim":"Better Therapeutics, Inc. received a nasdaq delisting notice notice regarding minimum bid price.","evidence_excerpt":"March 14, 2024. On March 14, 2024, the Company has voluntarily requested a delisting of its securities and expects its securities to be delisted in the near term. The Company further intends to file a Form 15 with the Securities and Exchange Commission to suspend its reporting obligations under the Securities Exchange Act of 1934, as amended.","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832415/000119312524067483/0001193125-24-067483-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"delisting notice"},{"label":"Deficiency","value":"minimum bid price"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}